Jun Park

1st January, 1970

Jun Park

Professional Career 

  • 2020-Present, a member of Global Pharma Key Opinion Leader (GPKOL) for CMC/cGMP, Korea Health Industry Development Institute 
  • 2020-Present: ILIAS Biologics, Chief Technology Officer, Daejeon, Korea 

Development of innovative exosome-based therapies that use exosomes as carriers for intracellular protein delivery. 

  • 2017-2019: Helixmith, SVP/Head of CMC, Seoul, Korea 

Development of gene therapies for neuromuscular diseases using plasmid DNA. 

  • 2006-2017: US FDA/CDER/Office of Biotechnology Products, Maryland, USA 

Worked as a CMC reviewer for biotech and biosimilar product reviews  

Participated in cGMP manufacturing facility inspections. 

  • 1999-2006: US DOD, Edgewood Chemical Biological Center, Maryland, USA 

Research on biologic agents and small-scale production of proteins, monoclonal antibodies, and enzymes. 

  • 1989-1999: Alpha-Beta Technology, Massachusetts, USA 

Development of carbohydrate-based therapies for immunomodulator or wound healing, etc. 



  • Worcester Polytechnic Institute, Ph.D., Biochemical Engineering, Massachusetts, USA 
  • KAIST, MS, Chemical Engineering, Seoul, Korea 
  • Yonsei University, BS, Chemical Engineering, Seoul, Korea 


Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the

If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:

Paul Adams
+44 (0)20 7936 6948

Speaker opportunities

We identify and invite individuals we believe to be the best speakers in the market, if you think you can make a difference to the quality of our events please contact:

Chloe Roberts
E: Chloe.Roberts@arena-international.com
T: +44 (0)207 936 6822